fbpx

Attorney Eric Berlin Dispels Rumors About Rescheduling

Welcome to the first Trade To Black podcast episode for November. With the elections happening on Tuesday, US Politics are top of nearly everyone’s minds. Dan the Chart Man joins us to discuss this week’s stock performances in the wake of anticipation for the results on both the presidential outcome as well as Florida’s Amendment 3. And Attorney Eric Berlin from Dentons join us to dispel rumors about the latest news involving rescheduling, explaining how the cannabis industry should interpret it.

The rescheduling hearing, which was initially anticipated for early December, will now include only procedural discussions. The substantive hearings where testimony will be presented have been pushed to the first quarter of 2025. Believe it or not, that may actually be a good thing for rescheduling. Berlin explains how this is not an actual delay but a procedural adjustment designed to allow the ALJ to confirm the legitimacy of all involved parties, and why that works in favor of pro-cannabis advocacy.

Rumors aside, the federal election results could also have an impact on the proceedings for rescheduling. The DEA has the ultimate authority on rescheduling, regardless of the recommendations of the ALJ in the upcoming hearing. A new administration appoints DEA leadership, and if there is a shift in administration, there’s a chance someone who opposes rescheduling might end up at the helm. The election could potentially delay rescheduling, which will have some financial implications for many in the industry.

How are things looking for Florida’s Amendment 3? The ballot initiative will be voted on the same day as the election. We’ll discuss some of the latest polling data, as well as the efforts of various campaigns for and against.

Plus, Dan from The Chart Guys will join us to discuss the weekly performance of cannabis stocks and outline what to prepare for as the decision on Amendment 3 approaches next week.


You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More